Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy: Comprehensive insights into pathology, immunology, and cutting-edge treatment strategies, integrating nanoparticles and ethnomedicinal plants

Kimta N, Majdalawieh AF, Nasrallah GK, et al. Frontiers Media SA. Frontiers in Pharmacology. 2024;
Download PDF
Publication

New developments in the antimicrobial treatment of leprosy

Gelber RH. Elsevier BV. Antimicrobic Newsletter. 1989; 6 (4) : 27-31.
Publication

Evidence of leprosy post exposure prophylaxis in highly endemic regions.

Wang H. The Lancet. Global health. 2024; 12 (6) : e905-e906.
Download PDF
Publication

A Case of Lepromatous Leprosy (Lucio's Phenomenon) Presenting as Periorbital Edema.

Swain D, Green M, Kupcha A. Ophthalmic plastic and reconstructive surgery. 2024;
Publication

Facial ulceration in a patient with lepromatous leprosy.

Somasundaram A, Sivakumar A, Arulnathan A, et al. International journal of dermatology. 2024;
Publication

Utility of cutaneous thermography in assessment of nerve function impairment in leprosy.

Vinay K, Baskaran N, Narang T, et al. International journal of dermatology. 2024;
Publication

Clinical-epidemiological profile of leprosy patients undergoing retreatment at a reference center in southeastern Brazil.

Bezerra G, Velho P, França A. Anais brasileiros de dermatologia. 2024;
Download PDF
Publication

Seroprevalence of Leprosy in Nine-Banded Armadillos (Dasypus novemcinctus) from Tennessee, USA, 2021-22.

Turner C, Loughry W, Perez-Heydrich C, et al. Journal of wildlife diseases. 2024;
Publication

Body map stories from Colombia: experiences of people affected by leprosy and the influence of peers during diagnosis and treatment

Barbosa Ladino MC, Jiménez Betancourth C, Vásquez Acevedo L, et al. Springer Science and Business Media LLC. International Journal for Equity in Health. 2024;
Download PDF
Publication

The WHO Skin NTD mobile application – a paradigm shift in leprosy diagnosis through Artificial Intelligence?

Quilter EEV, Butlin CR, Carrion C, et al. Lepra. Leprosy Review. 2024; 95 (2) : 1-3.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 105
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD